A simple and sensitive radioenzymatic assay for pyridoxal 5′ - Phosphate in human plasma

Pakistan Journal of Zoology

Volumn 35, Issue 3, 2003, Pages 231-235

  Iqbal, M Perwaiz ^a   Khan, Abrar Hussain ^a   Yousuf, Farzana Abubakar ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Acute myocardial infarction; Pyridoxal phosphate; Radioenzymatic assay; Vitamin B6

Indexed keywords

PHOSPHATE;

EID: 0142244762     PISSN: 00309923     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. BATES, C. J., PENTIEVA, K. D., PRENTICE, A., MANSOOR, M.A., AND FINCH, S., 1999. Plasma Pyridoxal phosphate and pyridoxic acid and their relationship to plasma homocysteine in a representative sample of British men and women aged 65 years and over. Br. J. Nutr., 81: 191-201.
2. BATES, C. J., PENTIEVA, K.D., MATTHEWS, N. AND MACDONALD, A., 1999. A simple, sensitive and reproducible assay for pyridoxal-5′ -phosphate and pyridoxic acid in human plasma. Clin. Chim. Acta, 280: 101-111.
3. CAMP, V.M., CHIPPONI, J. AND FARAJ, B.A., 1983. Radioenzymatic assay for direct measurement of plasma Pyridoxal 5′ -phosphate. Clin. Chem., 29: 642-644.
4. CATTANEO, M., LOMBARDI, R., LECCHI, A., BUCCIARELLI, P. AND MANNUCCI, P.M., 2001. Low plasma levels of vitamin B6 are independently associated with a heightened risk of deep-vein thrombosis. Circulation, 104:2442-2446.
5. EDWARDS, P., LIU, P.K. AND ROSE, G.A., 1989. A simple liquid-chromatographic method for measuring vitamin B6 compounds in plasma. Clin. Chem., 35: 241-5.
6. FARAJ, B.A., DAYTON, P.G., CAMP, V.M., WILSON, J.P., MALVEAUX, E.F. AND SCHLANT, R.C., 1977. Studies of the fate of tyraminc in dogs: The effect of monoamine oxidase inhibition, portafemoral shunt and coronary artery ligation on the kinetics of tyramine. J. Pharmacol. Exp. Ther., 200: 384-393.
7. FONDA, M.L., 1986. Evaluations of tyrosinc epodecarboxylase assays for pyridoxal phosphate. Ann. Biochem., 155: 14-22.
8. 14C(U) and a comparison with tryptophan load test. Scand. J. Lab. Invest., 20: 1-10.
9. HAN, Q., XU, M., TANG, L., TAN, X., TAN, X., TAN, Y. AND HOFFMAN, R.M., 2002. Homogeneous, nonradioactive, enzymatic assay for plasma pyridoxal 5′ -phosphate. Clin. Chem., 48: 1560-1564.
10. HANSEN, C.M., SHULTZ, T.D., KWAK, H.K., MEMON, H.S. AND LEKLEM, J.E., 2001. Assessment of vitamin B6 status in young women consuming a controlled diet containing four levels of vitamin B6 provides an estimated average requirement and recommended dietary allowance. J. Nutr., 131: 1777-1786.
11. INSTITUTE OF MEDICINE., 1998. DRI Reference Intake for Thiamin, Riboflavin, Niacin, Vitamin B6, folate, Vitamin B12, Pantothenic acid, Biolin and Cholin. National Academy Press, Washington, DC.
12. KULLER, L.H. AND EVANS, R,W., 1998. Homocysteine, vitamins, and cardiovascular disease. Circulation, 98: 196-199.
13. LEQUEU, B., GUILLAND, J. AND KLEPPING, J., 1985. Measurement of plasma pyridoxal 5′ -phosphate by combination of an enzymatic assay with high performance liquid chromatography/electrochemistry. Anal. Biochem., 149: 296-300.
14. PHAN, A.P., NGO, T.T. AND LENHOFF, H.M., 1983. Tyrosine decarboxylase spectrophotometric assay and application in determining pyridoxal-5′ -phosphate. Appl. Biochem. Biotechnol., 8: 127-133.
15. POON, H.C. AND SCHMIDT, B.M., 1991. Enzymatic fluorometric assay for plasma Pyridoxal 5′ -phosphate. Clin. Biochem., 24: 149-152.
16. ROBINSON K., MAYER E.L., MILLER, D.P., GREEN, R., VAN, LENTE F., GUPTA, A., KOTTKE-MARCHANT, K., SAVON, S.R., SELHUB, J., NISSEN, S.E., KUTNER, M., TOPOL, E.J. AND JACOBSON, D.W., 1995. Hyperhomocysteinemia and low pyridoxal phosphate, common and independent reversible risk factors for coronary artery disease. Circulation, 92: 2825-2830.
17. ROBINSON, K., ARHEART, K., REFSUM, H., BRATTSTROM, L., BOERS, G., UELAND, P., RUBBA, P., PALMAREIS, R., MELEADY, R., DALY, L., WITTEMAN, J. AND GRAHAM, I., 1998. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. Circulation, 97: 437-443.
18. SINGKAMANI, R., WORTHINGTON, D.J., THURNHAM, D.I. AND WHITEHEAD, T.P., 1986. A direct assay for pyridoxal 5′ -phosphate using pig heart apo-aspartate transaminase. Ann. Clin. Biochem., 23: 317-324.
19. TRONGPANISH, Y., MITO, M. AND YAGI, T., 2002. An enzymatic fluorometric assay for pyridoxal with high specificity and sensitivity. Biosci. Biotechnol. Biochem., 66: 1152-1154.
20. UBBINK, I.B., VERMAAK, W.J., VAN DER MERWE, A. AND BECKER, P.J., 1993. Vitamin B12, vitamin B6 and folate nutritional. status in men with hyperhomocysteinemia. Am.J. Clin. Nutr., 57: 47-53.
21. VERHOEF, P., STAMPFER, M.J., BURING, J.E., GAZIANO, J.M., ALLEN, R.H., STABLER, S.P., REYNOLDS, R.D., KOK, F.J., HENNEKENS, C.H. AND WILLET, W.C. 1996. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12 and folate. Am. J. Epidemiol., 143: 845-859.
22. YU, P.H., 1989. Determination of plasma pyridoxal 5′ -phosphate by an enzymatic-high performance liquid chromatographic procedure. Anal. Biochem., 181: 267-270.